10x Genomics’ (TXG) Sell (E+) Rating Reiterated at Weiss Ratings
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reissued by investment analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports. Other research analysts have also issued research reports about the stock. Ba…